Microbix Biosystems Stock Performance
| MBX Stock | CAD 0.22 0.01 4.35% |
The company secures a Beta (Market Risk) of 0.36, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Microbix Biosystems' returns are expected to increase less than the market. However, during the bear market, the loss of holding Microbix Biosystems is expected to be smaller as well. At this point, Microbix Biosystems has a negative expected return of -0.15%. Please make sure to verify Microbix Biosystems' total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Microbix Biosystems performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Microbix Biosystems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Ex Dividend Date 1999-09-02 |
1 | Stocks in play Microbix Biosystems Inc. - Barchart.com | 11/12/2025 |
2 | Trading Strategy and Analysis - news.stocktradersdaily.com | 12/01/2025 |
3 | Microbix Biosystems to Announce Q4 2025 Financial Results - The Globe and Mail | 12/12/2025 |
4 | Stock Trading Blueprint - news.stocktradersdaily.com | 12/16/2025 |
5 | Microbix Biosystems Inc Q4 2025 Earnings Call Highlights - GuruFocus | 12/23/2025 |
6 | Strategic Equity Report - Stock Traders Daily | 01/08/2026 |
7 | Stock Analysis and Trading Signals - Stock Traders Daily | 01/22/2026 |
| Begin Period Cash Flow | 13 M | |
| Total Cashflows From Investing Activities | -797.3 K |
Microbix |
Microbix Biosystems Relative Risk vs. Return Landscape
If you would invest 25.00 in Microbix Biosystems on November 5, 2025 and sell it today you would lose (3.00) from holding Microbix Biosystems or give up 12.0% of portfolio value over 90 days. Microbix Biosystems is producing return of less than zero assuming 3.3275% volatility of returns over the 90 days investment horizon. Simply put, 29% of all stocks have less volatile historical return distribution than Microbix Biosystems, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Microbix Biosystems Target Price Odds to finish over Current Price
The tendency of Microbix Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.22 | 90 days | 0.22 | over 95.63 |
Based on a normal probability distribution, the odds of Microbix Biosystems to move above the current price in 90 days from now is over 95.63 (This Microbix Biosystems probability density function shows the probability of Microbix Stock to fall within a particular range of prices over 90 days) .
Microbix Biosystems Price Density |
| Price |
Predictive Modules for Microbix Biosystems
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Microbix Biosystems. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Microbix Biosystems Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Microbix Biosystems is not an exception. The market had few large corrections towards the Microbix Biosystems' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Microbix Biosystems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Microbix Biosystems within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 0.36 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.06 |
Microbix Biosystems Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Microbix Biosystems for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Microbix Biosystems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Microbix Biosystems generated a negative expected return over the last 90 days | |
| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| Microbix Biosystems has high historical volatility and very poor performance | |
| Microbix Biosystems has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.59 M. Net Loss for the year was (2.25 M) with profit before overhead, payroll, taxes, and interest of 9.85 M. | |
| Microbix Biosystems has accumulated about 402.12 K in cash with (80.29 K) of positive cash flow from operations. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Stock Analysis and Trading Signals - Stock Traders Daily |
Microbix Biosystems Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Microbix Stock often depends not only on the future outlook of the current and potential Microbix Biosystems' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Microbix Biosystems' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 139.2 M | |
| Cash And Short Term Investments | 12.1 M |
Microbix Biosystems Fundamentals Growth
Microbix Stock prices reflect investors' perceptions of the future prospects and financial health of Microbix Biosystems, and Microbix Biosystems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microbix Stock performance.
| Return On Equity | -0.0801 | ||||
| Return On Asset | -0.0261 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 26.59 M | ||||
| Shares Outstanding | 138.81 M | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 1.65 X | ||||
| Revenue | 18.59 M | ||||
| Gross Profit | 9.85 M | ||||
| EBITDA | 428.23 K | ||||
| Net Income | (2.25 M) | ||||
| Cash And Equivalents | 402.12 K | ||||
| Total Debt | 6.77 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 1.64 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (80.29 K) | ||||
| Earnings Per Share | (0.02) X | ||||
| Market Capitalization | 30.58 M | ||||
| Total Asset | 37.41 M | ||||
| Retained Earnings | (35.64 M) | ||||
| Working Capital | 20.8 M | ||||
About Microbix Biosystems Performance
By examining Microbix Biosystems' fundamental ratios, stakeholders can obtain critical insights into Microbix Biosystems' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Microbix Biosystems is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 442.05 | 291.25 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.05) | (0.06) | |
| Return On Equity | (0.07) | (0.08) |
Things to note about Microbix Biosystems performance evaluation
Checking the ongoing alerts about Microbix Biosystems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microbix Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microbix Biosystems generated a negative expected return over the last 90 days | |
| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| Microbix Biosystems has high historical volatility and very poor performance | |
| Microbix Biosystems has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.59 M. Net Loss for the year was (2.25 M) with profit before overhead, payroll, taxes, and interest of 9.85 M. | |
| Microbix Biosystems has accumulated about 402.12 K in cash with (80.29 K) of positive cash flow from operations. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Stock Analysis and Trading Signals - Stock Traders Daily |
- Analyzing Microbix Biosystems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microbix Biosystems' stock is overvalued or undervalued compared to its peers.
- Examining Microbix Biosystems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microbix Biosystems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microbix Biosystems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Microbix Biosystems' stock. These opinions can provide insight into Microbix Biosystems' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.